Inhibition of γ-secretase by the CK1 inhibitor IC261 does not depend on CK1δ
…, K Baumann, R Schubenel, E Winkler, H Steiner…
Index: Hoettecke, Nicole; Liebeck, Miriam; Baumann, Karlheinz; Schubenel, Robert; Winkler, Edith; Steiner, Harald; Schmidt, Boris Bioorganic and Medicinal Chemistry Letters, 2010 , vol. 20, # 9 p. 2958 - 2963
Full Text: HTML
Citation Number: 11
Abstract
CK1 and γ-secretase are interesting targets for therapeutic intervention in the treatment of cancer and Alzheimer's disease. The CK1 inhibitor IC261 was reported to inhibit γ-secretase activity. The question is: Does CK1 inhibition directly influence γ-secretase activity? Therefore we analyzed the SAR of 15 analogues and their impact on γ-secretase activity. The most active compounds were investigated on CK1δ activity. These findings exclude a ...
Related Articles:
[Amombo, Ghislaine Marlyse Okala; Kramer, Thomas; Lo Monte, Fabio; Goering, Stefan; Fach, Matthias; Smith, Steven; Kolb, Stephanie; Schubenel, Robert; Baumann, Karlheinz; Schmidt, Boris Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 24 p. 7634 - 7640]
[Nate; Matsuki; Tsunashima; Ohtsuka; Sekine; Oda; Honma; Ishida; Nakai; Wada Chemical and Pharmaceutical Bulletin, 1987 , vol. 35, # 6 p. 2394 - 2411]
[Heerding, Dirk A.; Christmann, Lisa T.; Clark, Tammy J.; Holmes, David J.; Rittenhouse, Stephen F.; Takata, Dennis T.; Venslavsky, Joseph W. Bioorganic and Medicinal Chemistry Letters, 2003 , vol. 13, # 21 p. 3771 - 3773]
[Nesunts, N. S.; Avetisyan, S. A.; Dzhagatspanyan, I. A.; Akopyan, N. E.; Mndzhoyan, O. L. Pharmaceutical Chemistry Journal, 1983 , vol. 17, # 7 p. 480 - 484 Khimiko-Farmatsevticheskii Zhurnal, 1983 , vol. 17, # 7 p. 801 - 806]